US FDA clarifies which device modifications will need a new 510(k) submission
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has issued for comments a draft guideline that aims to better clarify which changes a manufacturer makes to an already marketed device will warrant the submission of a new pre-market notification, or 510(k), application.